Mandibular resection and reconstruction in the management of extensive ameloblastoma: our experience

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Mandibular resection and reconstruction in the management of extensive ameloblastoma: our experience

Purpose: To present our experience with the management of 33 extensive mandibular ameloblastomas treated with segmental mandibulectomy, reconstruction with free fibula or iliac crest flap, and rehabilitation with immediate or…

read more

Development of a proficiency based microsurgical training course and the demonstration of progression of junior OMFS trainees

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Development of a proficiency based microsurgical training course and the demonstration of progression of junior OMFS trainees

Introduction: It is recognized that simulation can be used to aid the training of surgeons. Many courses give participants a certificate of completion rather than one of competence or proficiency….

read more

Low Annexin A1 expression is predictive for a benefit from induction chemotherapy in oral cancer patients with moderately/poorly pathologic differentiation grade

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Low Annexin A1 expression is predictive for a benefit from induction chemotherapy in oral cancer patients with moderately/poorly pathologic differentiation grade

Background: The benefits of induction chemotherapy in oral squamous cell carcinoma (OSCC) remain to be clearly defined, as trials to date have not shown a major survival benefit when induction…

read more

Propranolol inhibited angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Propranolol inhibited angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell

Oral propranolol (PRN) has recently been shown to be highly effective for infantile hemangiomas (IHs), and is currently recommended as the first-line treatment of complicated IHs. However, no pharmacokinetic parameters…

read more
Get VIDEdental app for watching clinical videos